↓ Skip to main content

Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial

Overview of attention for article published in Supportive Care in Cancer, June 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
twitter
6 X users

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
221 Mendeley
Title
Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial
Published in
Supportive Care in Cancer, June 2015
DOI 10.1007/s00520-015-2810-x
Pubmed ID
Authors

Janelle Yorke, Mari Lloyd-Williams, Jacky Smith, Fiona Blackhall, Amelie Harle, June Warden, Jackie Ellis, Mark Pilling, Jemma Haines, Karen Luker, Alex Molassiotis

Abstract

Breathlessness, cough and fatigue are distressing symptoms for patients with lung cancer. There is evidence that these three symptoms form a discreet symptom cluster. This study aimed to feasibly test a new non-pharmacological intervention for the management of the Respiratory Distress Symptom Cluster (breathlessness-cough-fatigue) in lung cancer. This was a multi-centre, randomised controlled non-blinded parallel group feasibility trial. Eligible patients (patients with primary lung cancer and 'bothered' by at least two of the three cluster symptoms) received usual care plus a multicomponent intervention delivered over two intervention training sessions and a follow-up telephone call or usual care only. Follow-up was for 12 weeks, and end-points included six numerical rating scales for breathlessness severity, Dyspnoea-12, Manchester Cough in Lung Cancer scale, FACIT-Fatigue scale, Hospital Anxiety and Depression scale, Lung Cancer Symptom Scale and the EQ-5D-3L, collected at baseline, week 4 and week 12. One hundred seven patients were randomised over 8 months; however, six were removed from further analysis due to protocol violations (intervention group n = 50 and control group n = 51). Of the ineligible patients (n = 608), 29 % reported either not experiencing two or more symptoms or not being 'bothered' by at least two symptoms. There was 29 % drop-out by week 4, and by week 12, a further two patients in the control group were lost to follow-up. A sample size calculation indicated that 122 patients per arm would be needed to detect a clinically important difference in the main outcome for breathlessness, cough and fatigue. The study has provided evidence of the feasibility and acceptability of a new intervention in the lung cancer population and warrants a fully powered trial before we reach any conclusions. The follow-on trial will test the hypothesis that the intervention improves symptom cluster of breathlessness, cough and fatigue better than usual care alone. Full economic evaluation will be conducted in the main trial.

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 221 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
United States 1 <1%
Unknown 218 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 34 15%
Student > Master 27 12%
Student > Ph. D. Student 22 10%
Researcher 18 8%
Other 11 5%
Other 33 15%
Unknown 76 34%
Readers by discipline Count As %
Nursing and Health Professions 58 26%
Medicine and Dentistry 35 16%
Psychology 9 4%
Sports and Recreations 6 3%
Agricultural and Biological Sciences 4 2%
Other 25 11%
Unknown 84 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 September 2021.
All research outputs
#2,576,706
of 24,496,759 outputs
Outputs from Supportive Care in Cancer
#469
of 4,901 outputs
Outputs of similar age
#32,111
of 268,277 outputs
Outputs of similar age from Supportive Care in Cancer
#7
of 73 outputs
Altmetric has tracked 24,496,759 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,901 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 268,277 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 73 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.